PYGL is the liver isoform of glycogen phosphorylase, the rate-limiting enzyme of glycogenolysis. It is a pyridoxal-5'-phosphate-dependent homodimeric enzyme that phosphorolytically cleaves the alpha-1,4-glycosidic bonds at the non-reducing ends of glycogen, releasing glucose-1-phosphate, and stops about four residues short of alpha-1,6 branch points (which are then processed by the glycogen debranching enzyme). Activity is controlled allosterically (activated by AMP; inhibited by ATP, ADP and glucose-6-phosphate) and covalently by interconversion between an inactive phosphorylase b and an active phosphorylase a form via phosphorylation of Ser15 by phosphorylase kinase and dephosphorylation by protein phosphatase 1. The enzyme acts in the cytosol, predominantly in the liver, where it liberates glucose from stored glycogen to maintain blood glucose during fasting. Loss-of-function variants cause glycogen storage disease type VI (Hers disease), characterized by hepatomegaly and usually mild fasting hypoglycemia.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005829
cytosol
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Glycogen phosphorylase is a soluble cytosolic enzyme; UniProt records the subcellular location as Cytoplasm, cytosol, and this IBA is concordant with Reactome TAS and UniProt-SubCell IEA assignments.
Reason: Cytosol is the correct and well-supported site of action for this cytosolic glycogenolytic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0005980
glycogen catabolic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: PYGL catalyzes the rate-limiting step of glycogen breakdown, so glycogen catabolic process is its core biological process. This is the correct level of specificity and is supported across the phylogenetic tree of glycogen phosphorylases.
Reason: Glycogen catabolic process is the precise, core biological process of the enzyme; well supported by IBA, experimental data and UniProt.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes the rate-limiting step in glycogen catabolism and plays a key role in maintaining cellular and organismal glucose homeostasis.
|
|
GO:0008184
glycogen phosphorylase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Glycogen phosphorylase activity is the defining molecular function of PYGL. The IBA is concordant with direct experimental measurement of catalytic activity on human liver GP and with the EC 2.4.1.1 assignment.
Reason: This is the core catalytic molecular function of the gene product, supported by phylogeny and by direct assay.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
|
|
GO:0004645
1,4-alpha-oligoglucan phosphorylase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: This is the EC 2.4.1.1 / RHEA:41732 catalytic activity term (the parent of glycogen phosphorylase activity), assigned by automated pipelines from InterPro and the RHEA reaction. It correctly describes the phosphorolysis of alpha-1,4 glucan bonds and is experimentally confirmed for the human enzyme.
Reason: Correct EC-mapped catalytic activity term; consistent with the experimentally determined reaction and with the more specific glycogen phosphorylase activity term also annotated.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
EC=2.4.1.1 {ECO:0000269|PubMed:22225877}
|
|
GO:0005829
cytosol
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Cytosol assigned automatically from the UniProt subcellular-location vocabulary (SL-0091), consistent with the curated Cytoplasm, cytosol location and with the IBA and Reactome TAS cytosol annotations.
Reason: Correct localization for this cytosolic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0005975
carbohydrate metabolic process
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: Broad InterPro-derived process term. It is correct but much more general than the specific glycogen catabolic process that captures PYGL's actual role.
Reason: Not wrong, but a high-level parent superseded by the specific glycogen catabolic process annotation; retained as a general, non-core term.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
|
|
GO:0005977
glycogen metabolic process
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: ARBA machine-learning process term. Correct but a general parent of glycogen catabolic process, which is the precise role of the enzyme.
Reason: Correct but general; the specific glycogen catabolic process term is the core BP. Retained as a broad, non-core annotation.
Supporting Evidence:
PMID:22225877
GP activity plays an important role in glucose homeostasis and glycogen metabolism.
|
|
GO:0008184
glycogen phosphorylase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated assignment of the core catalytic molecular function from InterPro/ARBA and mouse ortholog, redundant with and confirmed by the IBA and experimental (IDA/IMP/EXP) annotations to the same term.
Reason: Correctly captures the defining catalytic activity of PYGL.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
|
|
GO:0030170
pyridoxal phosphate binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: Pyridoxal 5'-phosphate is the essential cofactor of glycogen phosphorylase, covalently bound via a Schiff base to Lys681. This InterPro-based IEA is strongly supported by the curated cofactor annotation and multiple crystal structures.
Reason: PLP binding is a genuine, essential cofactor-binding function of the enzyme (Lys681 pyridoxal-phosphate attachment site).
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
MARK AS OVER ANNOTATED |
Summary: Interaction detected in a large-scale binary interactome map; the GOA with/from is PYGB (P11216), the brain glycogen phosphorylase isoform. The bare protein binding term is uninformative about function.
Reason: Bare protein binding gives no functional insight; the underlying PYGB interaction reflects glycogen-phosphorylase isoform association captured more informatively by the identical protein binding (homodimer) annotation. Retained but flagged as over-annotation per curation guidelines.
|
|
GO:0005515
protein binding
|
IPI
PMID:25910212 Widespread macromolecular interaction perturbations in human... |
MARK AS OVER ANNOTATED |
Summary: Interaction from a systematic interactome-perturbation study; with/from is PYGB (P11216). The bare protein binding term is uninformative.
Reason: Uninformative protein binding term; the PYGB partner reflects glycogen phosphorylase isoform association rather than a distinct function. Retained but flagged as over-annotation.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Interactions from a reference human binary interactome; with/from are PYGB (P11216) and PYGM (P11217), the other glycogen phosphorylase isoforms. The bare protein binding term is uninformative.
Reason: Uninformative protein binding term; the PYGB/PYGM partners reflect glycogen phosphorylase isoform association. Retained but flagged as over-annotation.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Interaction from a cell-specific interactome-remodeling map; with/from is PYGB (P11216). The bare protein binding term is uninformative.
Reason: Uninformative protein binding term; PYGB partner reflects glycogen phosphorylase isoform association. Retained but flagged as over-annotation.
|
|
GO:0005980
glycogen catabolic process
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Automated orthology-based transfer (from mouse Pygl, Q9ET01) of the core glycogen catabolic process, redundant with and confirmed by the IBA annotation to the same term.
Reason: Correctly captures the core biological process of the enzyme; concordant with the IBA and with experimental evidence.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes the rate-limiting step in glycogen catabolism and plays a key role in maintaining cellular and organismal glucose homeostasis.
|
|
GO:0004645
1,4-alpha-oligoglucan phosphorylase activity
|
EXP
PMID:22225877 Acetylation negatively regulates glycogen phosphorylase by r... |
ACCEPT |
Summary: Zhang et al. directly assayed the phosphorolytic activity of purified human GP, establishing the EC 2.4.1.1 catalytic activity experimentally. This is the EC-mapped parent of glycogen phosphorylase activity.
Reason: Experimentally supported core catalytic function; the enzyme phosphorolyses alpha-1,4 glucan bonds to yield glucose-1-phosphate.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
|
|
GO:0005536
D-glucose binding
|
IDA
PMID:10980448 Human liver glycogen phosphorylase inhibitors bind at a new ... |
ACCEPT |
Summary: Crystallographic study of human liver glycogen phosphorylase; glucose is a physiological allosteric inhibitor that binds the enzyme and stabilizes the inactive conformation. The cached record is abstract-only, so the full ligand-binding detail read by the curator is not directly quotable here.
Reason: D-glucose binding is a genuine, physiologically relevant ligand-binding function (product/end-product feedback inhibitor) demonstrated structurally for the human enzyme; experimental IDA, deferring to the full text read by the curator.
Supporting Evidence:
PMID:10980448
functions allosterically by stabilizing the inactive
|
|
GO:0005536
D-glucose binding
|
IDA
PMID:12204691 Structure-activity analysis of the purine binding site of hu... |
ACCEPT |
Summary: Structure-activity study of human liver GP allosteric sites by crystallography and SPR. D-glucose binding is a genuine allosteric-ligand function; cached record is abstract-only.
Reason: Experimentally supported ligand-binding function of the human enzyme; duplicate of the other D-glucose binding IDA, deferring to full text read by the curator.
Supporting Evidence:
PMID:12204691
regulated by multiple interacting allosteric sites, each of which is a potential
|
|
GO:0042802
identical protein binding
|
IPI
PMID:10980448 Human liver glycogen phosphorylase inhibitors bind at a new ... |
ACCEPT |
Summary: PYGL is enzymatically active as a homodimer, as established by the crystal structures of human liver GP (with/from P06737, self-interaction). This is the functionally relevant, informative self-association.
Reason: The homodimer is the biologically active unit of glycogen phosphorylase; identical protein binding correctly and informatively captures the self-association (unlike bare protein binding).
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBUNIT: Homodimer; enzymatically active
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-6798748 |
MARK AS OVER ANNOTATED |
Summary: Assigned via a Reactome neutrophil-degranulation/secretory-granule exocytosis module. PYGL is a cytosolic glycogenolytic enzyme; its presence in the extracellular region reflects secretome/degranulation cataloguing rather than a site of function.
Reason: PYGL functions in the cytosol; extracellular localization is a bystander catalog assignment from a degranulation pathway, not a functional location.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0005576
extracellular region
|
TAS
Reactome:R-HSA-6800434 |
MARK AS OVER ANNOTATED |
Summary: Same as the other extracellular-region assignment, from a Reactome ficolin-rich granule exocytosis module. Not a functional location for this cytosolic enzyme.
Reason: Bystander secretome/degranulation catalog assignment; PYGL acts in the cytosol.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0034774
secretory granule lumen
|
TAS
Reactome:R-HSA-6798748 |
MARK AS OVER ANNOTATED |
Summary: From a Reactome secretory-granule exocytosis module. PYGL is cytosolic; granule-lumen localization is a bystander proteomic/degranulation catalog assignment, not a functional site.
Reason: Not a functional location for this cytosolic glycogenolytic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:1904813
ficolin-1-rich granule lumen
|
TAS
Reactome:R-HSA-6800434 |
MARK AS OVER ANNOTATED |
Summary: From a Reactome ficolin-rich granule exocytosis module. As with the other granule/extracellular assignments, this is a bystander catalog location, not the functional site of the cytosolic enzyme.
Reason: Not a functional location for this cytosolic glycogenolytic enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres... |
MARK AS OVER ANNOTATED |
Summary: PYGL was detected among ~900 proteins in a shotgun proteomic survey of exosomes from prostatic secretions in urine. This is a high-throughput proteome-cataloguing localization, not evidence of a functional exosomal role for this cytosolic enzyme.
Reason: Detection in an exosome proteome catalog does not indicate a functional site; PYGL acts in the cytosol.
Supporting Evidence:
PMID:23533145
In pooled EPS-urine exosome samples, ~900 proteins were detected.
|
|
GO:0008184
glycogen phosphorylase activity
|
IDA
PMID:22225877 Acetylation negatively regulates glycogen phosphorylase by r... |
ACCEPT |
Summary: Zhang et al. directly measured the glycogen phosphorylase catalytic activity of purified human GP (and its regulation by acetylation/PP1), providing direct experimental evidence for this core molecular function.
Reason: Direct experimental demonstration of the core catalytic activity of PYGL.
Supporting Evidence:
PMID:22225877
Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when body glucose is scarce.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-453339 |
ACCEPT |
Summary: Reactome cytosol assignment for the glycogenolysis reaction (glycogen + phosphate to glucose-1-phosphate). This is the correct functional location for PYGL.
Reason: Cytosol is the correct site of the glycogenolytic reaction catalyzed by PYGL; concordant with IBA and UniProt.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-71588 |
ACCEPT |
Summary: Reactome cytosol assignment for the phosphorylase b to a interconversion reaction. Correct functional location.
Reason: Cytosol is the correct site of action; concordant with IBA and UniProt.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-71590 |
ACCEPT |
Summary: Reactome cytosol assignment for glycogen limit-dextrin formation with release of glucose-1-phosphate. Correct functional location.
Reason: Cytosol is the correct site of the glycogenolytic reaction; concordant with IBA and UniProt.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
SUBCELLULAR LOCATION: Cytoplasm, cytosol
|
|
GO:0002060
purine nucleobase binding
|
IDA
PMID:12204691 Structure-activity analysis of the purine binding site of hu... |
MARK AS OVER ANNOTATED |
Summary: Derived from a crystallographic/SPR structure-activity screen of ligands at the purine allosteric inhibitor site of human liver GP, a drug-discovery target site. This binding is real structurally but peripheral to the enzyme's biological function.
Reason: Purine-nucleobase binding reflects a pharmacological/inhibitor-screen site rather than a core physiological binding function; retained but flagged as over-annotation. Not removed, as it is an experimental IDA.
Supporting Evidence:
PMID:12204691
compounds that bind to the purine allosteric inhibitor site.
|
|
GO:0005524
ATP binding
|
IDA
PMID:10949035 Activation of human liver glycogen phosphorylase by alterati... |
ACCEPT |
Summary: ATP is a physiological allosteric inhibitor of glycogen phosphorylase, binding at the nucleotide (AMP) allosteric site; UniProt records inhibition by ATP among the allosteric controls. The cited crystallographic study of the active/inactive human liver GP is abstract-only in the cache.
Reason: ATP binding at the allosteric nucleotide site is a genuine regulatory binding function of the enzyme (ATP inhibits GP); experimental IDA, deferring to the full text read by the curator.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
being activated by AMP and inhibited by ATP,
|
|
GO:0005977
glycogen metabolic process
|
IMP
PMID:10980448 Human liver glycogen phosphorylase inhibitors bind at a new ... |
KEEP AS NON CORE |
Summary: Involvement in glycogen metabolism supported by structural/functional study of the human liver enzyme. This is a correct but general parent of the specific glycogen catabolic process, which better captures PYGL's role.
Reason: Correct but general; glycogen catabolic process is the precise core BP. Retained as non-core.
Supporting Evidence:
PMID:10980448
Glycogen phosphorylases catalyze the breakdown of glycogen to glucose-1-phosphate for glycolysis.
|
|
GO:0005977
glycogen metabolic process
|
IMP
PMID:17705025 High frequency of missense mutations in glycogen storage dis... |
KEEP AS NON CORE |
Summary: GSD6 patients with PYGL mutations show impaired mobilization of glucose from glycogen, implicating PYGL in glycogen metabolism. Correct but a general parent of the specific glycogen catabolic process.
Reason: Correct but general; glycogen catabolic process is the precise core BP. Retained as non-core.
Supporting Evidence:
PMID:17705025
reduced ability to mobilize glucose from glycogen
|
|
GO:0008184
glycogen phosphorylase activity
|
IMP
PMID:10980448 Human liver glycogen phosphorylase inhibitors bind at a new ... |
ACCEPT |
Summary: Study of the human liver enzyme (active and inactive forms) supports its glycogen phosphorylase catalytic activity. Redundant with the IDA/EXP/IBA annotations to the same core function.
Reason: Correctly captures the core catalytic activity of PYGL.
Supporting Evidence:
PMID:10980448
Glycogen phosphorylases catalyze the breakdown of glycogen to glucose-1-phosphate for glycolysis.
|
|
GO:0008184
glycogen phosphorylase activity
|
IMP
PMID:17705025 High frequency of missense mutations in glycogen storage dis... |
ACCEPT |
Summary: GSD6-causing missense mutations in PYGL impair enzyme activity, supporting that PYGL enables glycogen phosphorylase activity. Concordant with the core catalytic function.
Reason: Disease mutations that reduce enzyme activity support this core molecular function.
Supporting Evidence:
PMID:17705025
reduced ability to mobilize glucose from glycogen
|
|
GO:0008184
glycogen phosphorylase activity
|
IMP
PMID:9529348 Mutations in the liver glycogen phosphorylase gene (PYGL) un... |
ACCEPT |
Summary: First identification of PYGL mutations in Hers disease patients, demonstrating that PYGL encodes the liver glycogen phosphorylase whose deficiency abolishes activity. Supports this core molecular function.
Reason: Disease-causing loss-of-function mutations in PYGL support that it enables glycogen phosphorylase activity.
Supporting Evidence:
PMID:9529348
Deficiency of glycogen phosphorylase in the liver gives rise to glycogen-storage disease type VI (Hers disease; MIM 232700).
|
|
GO:0016208
AMP binding
|
IDA
PMID:10949035 Activation of human liver glycogen phosphorylase by alterati... |
ACCEPT |
Summary: AMP is the classical physiological allosteric activator of glycogen phosphorylase; the crystal structure of human liver GP in complex with AMP was solved (UniProt records AMP-binding residues 43-45, 76, 310), and UniProt notes activation by AMP. A genuine, physiologically important ligand-binding function.
Reason: AMP binding at the allosteric activator site is a core regulatory binding function of the enzyme; supported by structure and by curated binding-site annotation.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
being activated by AMP and inhibited by ATP,
|
|
GO:0016208
AMP binding
|
IDA
PMID:10980448 Human liver glycogen phosphorylase inhibitors bind at a new ... |
ACCEPT |
Summary: Structural study of human liver GP; AMP is the physiological allosteric activator that binds the nucleotide effector site. Duplicate of the other AMP binding IDA; a core regulatory binding function.
Reason: AMP binding at the allosteric activator site is a genuine, physiologically important binding function of the enzyme.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
being activated by AMP and inhibited by ATP,
|
|
GO:0019842
vitamin binding
|
IDA
PMID:12204691 Structure-activity analysis of the purine binding site of hu... |
MARK AS OVER ANNOTATED |
Summary: Vitamin binding here refers to the bound pyridoxal 5'-phosphate cofactor (a vitamin B6 derivative) seen in the crystal structures. This is a very general term that is captured more precisely by the pyridoxal phosphate binding annotation.
Reason: Overly general term; the specific and informative pyridoxal phosphate binding term already annotated supersedes it. Retained but flagged.
Supporting Evidence:
file:human/PYGL/PYGL-uniprot.txt
Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
|
|
GO:0032052
bile acid binding
|
IDA
PMID:12204691 Structure-activity analysis of the purine binding site of hu... |
MARK AS OVER ANNOTATED |
Summary: Derived from the same crystallographic/SPR ligand screen of the purine allosteric inhibitor site. Bile-acid binding at a drug-target allosteric pocket is a pharmacological observation, not a physiological function of the enzyme.
Reason: Reflects binding of screened ligands at a drug-discovery allosteric site rather than a biological function; retained but flagged as over-annotation. Not removed, as it is an experimental IDA.
Supporting Evidence:
PMID:12204691
compounds that bind to the purine allosteric inhibitor site.
|
|
GO:0042593
glucose homeostasis
|
IMP
PMID:17705025 High frequency of missense mutations in glycogen storage dis... |
KEEP AS NON CORE |
Summary: GSD6 caused by PYGL deficiency presents with fasting hypoglycemia, demonstrating that PYGL contributes to organismal glucose homeostasis by mobilizing glucose from hepatic glycogen. This is a physiological, systemic role downstream of the core enzymatic function.
Reason: Genuine organismal/physiological role, but downstream of and secondary to the core glycogen catabolic/enzymatic function; retained as non-core.
Supporting Evidence:
PMID:17705025
reduced ability to mobilize glucose from glycogen
|
UniProt: P06737 (PYGL_HUMAN), 847 aa, HGNC:9725, chromosome 14. EC 2.4.1.1.
FT MOD_RES 681 N6-(pyridoxal phosphate)lysine).[(1->4)-alpha-D-glucosyl](n) + phosphate =
[(1->4)-alpha-D-glucosyl](n-1) + alpha-D-glucose 1-phosphate. Phosphorolysesglycogen phosphorylase activity and1,4-alpha-oligoglucan phosphorylase activity annotations.vitamin binding, bile acid binding, purine nucleobase binding are generic/protein binding (GO:0005515) IPIs (PMID:25416956, 25910212, 32296183, 33961781):identical protein binding (GO:0042802, IPI, PMID:10980448, with/from P06737):glucose homeostasis (GO:0042593, IMP, PMID:17705025): GSD6 phenotype (fastingid: P06737
gene_symbol: PYGL
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: PYGL is the liver isoform of glycogen phosphorylase, the rate-limiting
enzyme of glycogenolysis. It is a pyridoxal-5'-phosphate-dependent homodimeric enzyme
that phosphorolytically cleaves the alpha-1,4-glycosidic bonds at the non-reducing
ends of glycogen, releasing glucose-1-phosphate, and stops about four residues short
of alpha-1,6 branch points (which are then processed by the glycogen debranching
enzyme). Activity is controlled allosterically (activated by AMP; inhibited by ATP,
ADP and glucose-6-phosphate) and covalently by interconversion between an inactive
phosphorylase b and an active phosphorylase a form via phosphorylation of Ser15 by
phosphorylase kinase and dephosphorylation by protein phosphatase 1. The enzyme acts
in the cytosol, predominantly in the liver, where it liberates glucose from stored
glycogen to maintain blood glucose during fasting. Loss-of-function variants cause
glycogen storage disease type VI (Hers disease), characterized by hepatomegaly and
usually mild fasting hypoglycemia.
alternative_products:
- name: '1'
id: P06737-1
- name: '2'
id: P06737-2
sequence_note: VSP_045339
existing_annotations:
- term:
id: GO:0005829
label: cytosol
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: Glycogen phosphorylase is a soluble cytosolic enzyme; UniProt records
the subcellular location as Cytoplasm, cytosol, and this IBA is concordant with
Reactome TAS and UniProt-SubCell IEA assignments.
action: ACCEPT
reason: Cytosol is the correct and well-supported site of action for this
cytosolic glycogenolytic enzyme.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0005980
label: glycogen catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: PYGL catalyzes the rate-limiting step of glycogen breakdown, so glycogen
catabolic process is its core biological process. This is the correct level of
specificity and is supported across the phylogenetic tree of glycogen
phosphorylases.
action: ACCEPT
reason: Glycogen catabolic process is the precise, core biological process of the
enzyme; well supported by IBA, experimental data and UniProt.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes the rate-limiting step
in glycogen catabolism and plays a key role in maintaining cellular and
organismal glucose homeostasis.
- term:
id: GO:0008184
label: glycogen phosphorylase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Glycogen phosphorylase activity is the defining molecular function of
PYGL. The IBA is concordant with direct experimental measurement of catalytic
activity on human liver GP and with the EC 2.4.1.1 assignment.
action: ACCEPT
reason: This is the core catalytic molecular function of the gene product,
supported by phylogeny and by direct assay.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
body glucose is scarce.
- term:
id: GO:0004645
label: 1,4-alpha-oligoglucan phosphorylase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: This is the EC 2.4.1.1 / RHEA:41732 catalytic activity term (the parent
of glycogen phosphorylase activity), assigned by automated pipelines from
InterPro and the RHEA reaction. It correctly describes the phosphorolysis of
alpha-1,4 glucan bonds and is experimentally confirmed for the human enzyme.
action: ACCEPT
reason: Correct EC-mapped catalytic activity term; consistent with the
experimentally determined reaction and with the more specific glycogen
phosphorylase activity term also annotated.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: EC=2.4.1.1 {ECO:0000269|PubMed:22225877}
- term:
id: GO:0005829
label: cytosol
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Cytosol assigned automatically from the UniProt subcellular-location
vocabulary (SL-0091), consistent with the curated Cytoplasm, cytosol location
and with the IBA and Reactome TAS cytosol annotations.
action: ACCEPT
reason: Correct localization for this cytosolic enzyme.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: Broad InterPro-derived process term. It is correct but much more general
than the specific glycogen catabolic process that captures PYGL's actual role.
action: KEEP_AS_NON_CORE
reason: Not wrong, but a high-level parent superseded by the specific glycogen
catabolic process annotation; retained as a general, non-core term.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
body glucose is scarce.
- term:
id: GO:0005977
label: glycogen metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: ARBA machine-learning process term. Correct but a general parent of
glycogen catabolic process, which is the precise role of the enzyme.
action: KEEP_AS_NON_CORE
reason: Correct but general; the specific glycogen catabolic process term is the
core BP. Retained as a broad, non-core annotation.
supported_by:
- reference_id: PMID:22225877
supporting_text: GP activity plays an important role in glucose homeostasis and
glycogen metabolism.
- term:
id: GO:0008184
label: glycogen phosphorylase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Automated assignment of the core catalytic molecular function from
InterPro/ARBA and mouse ortholog, redundant with and confirmed by the IBA and
experimental (IDA/IMP/EXP) annotations to the same term.
action: ACCEPT
reason: Correctly captures the defining catalytic activity of PYGL.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
body glucose is scarce.
- term:
id: GO:0030170
label: pyridoxal phosphate binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: Pyridoxal 5'-phosphate is the essential cofactor of glycogen
phosphorylase, covalently bound via a Schiff base to Lys681. This InterPro-based
IEA is strongly supported by the curated cofactor annotation and multiple crystal
structures.
action: ACCEPT
reason: PLP binding is a genuine, essential cofactor-binding function of the enzyme
(Lys681 pyridoxal-phosphate attachment site).
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: Interaction detected in a large-scale binary interactome map; the GOA
with/from is PYGB (P11216), the brain glycogen phosphorylase isoform. The bare
protein binding term is uninformative about function.
action: MARK_AS_OVER_ANNOTATED
reason: Bare protein binding gives no functional insight; the underlying PYGB
interaction reflects glycogen-phosphorylase isoform association captured more
informatively by the identical protein binding (homodimer) annotation. Retained
but flagged as over-annotation per curation guidelines.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25910212
qualifier: enables
review:
summary: Interaction from a systematic interactome-perturbation study; with/from
is PYGB (P11216). The bare protein binding term is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative protein binding term; the PYGB partner reflects glycogen
phosphorylase isoform association rather than a distinct function. Retained but
flagged as over-annotation.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: Interactions from a reference human binary interactome; with/from are
PYGB (P11216) and PYGM (P11217), the other glycogen phosphorylase isoforms. The
bare protein binding term is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative protein binding term; the PYGB/PYGM partners reflect
glycogen phosphorylase isoform association. Retained but flagged as
over-annotation.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: Interaction from a cell-specific interactome-remodeling map; with/from is
PYGB (P11216). The bare protein binding term is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: Uninformative protein binding term; PYGB partner reflects glycogen
phosphorylase isoform association. Retained but flagged as over-annotation.
- term:
id: GO:0005980
label: glycogen catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: involved_in
review:
summary: Automated orthology-based transfer (from mouse Pygl, Q9ET01) of the core
glycogen catabolic process, redundant with and confirmed by the IBA annotation
to the same term.
action: ACCEPT
reason: Correctly captures the core biological process of the enzyme; concordant
with the IBA and with experimental evidence.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes the rate-limiting step
in glycogen catabolism and plays a key role in maintaining cellular and
organismal glucose homeostasis.
- term:
id: GO:0004645
label: 1,4-alpha-oligoglucan phosphorylase activity
evidence_type: EXP
original_reference_id: PMID:22225877
qualifier: enables
review:
summary: Zhang et al. directly assayed the phosphorolytic activity of purified
human GP, establishing the EC 2.4.1.1 catalytic activity experimentally. This is
the EC-mapped parent of glycogen phosphorylase activity.
action: ACCEPT
reason: Experimentally supported core catalytic function; the enzyme phosphorolyses
alpha-1,4 glucan bonds to yield glucose-1-phosphate.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
body glucose is scarce.
- term:
id: GO:0005536
label: D-glucose binding
evidence_type: IDA
original_reference_id: PMID:10980448
qualifier: enables
review:
summary: Crystallographic study of human liver glycogen phosphorylase; glucose is
a physiological allosteric inhibitor that binds the enzyme and stabilizes the
inactive conformation. The cached record is abstract-only, so the full
ligand-binding detail read by the curator is not directly quotable here.
action: ACCEPT
reason: D-glucose binding is a genuine, physiologically relevant ligand-binding
function (product/end-product feedback inhibitor) demonstrated structurally for
the human enzyme; experimental IDA, deferring to the full text read by the
curator.
supported_by:
- reference_id: PMID:10980448
supporting_text: functions allosterically by stabilizing the inactive
- term:
id: GO:0005536
label: D-glucose binding
evidence_type: IDA
original_reference_id: PMID:12204691
qualifier: enables
review:
summary: Structure-activity study of human liver GP allosteric sites by
crystallography and SPR. D-glucose binding is a genuine allosteric-ligand
function; cached record is abstract-only.
action: ACCEPT
reason: Experimentally supported ligand-binding function of the human enzyme;
duplicate of the other D-glucose binding IDA, deferring to full text read by
the curator.
supported_by:
- reference_id: PMID:12204691
supporting_text: regulated by multiple interacting allosteric sites, each of
which is a potential
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:10980448
qualifier: enables
review:
summary: PYGL is enzymatically active as a homodimer, as established by the
crystal structures of human liver GP (with/from P06737, self-interaction). This
is the functionally relevant, informative self-association.
action: ACCEPT
reason: The homodimer is the biologically active unit of glycogen phosphorylase;
identical protein binding correctly and informatively captures the
self-association (unlike bare protein binding).
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBUNIT: Homodimer; enzymatically active"
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798748
qualifier: located_in
review:
summary: Assigned via a Reactome neutrophil-degranulation/secretory-granule
exocytosis module. PYGL is a cytosolic glycogenolytic enzyme; its presence in
the extracellular region reflects secretome/degranulation cataloguing rather
than a site of function.
action: MARK_AS_OVER_ANNOTATED
reason: PYGL functions in the cytosol; extracellular localization is a bystander
catalog assignment from a degranulation pathway, not a functional location.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0005576
label: extracellular region
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6800434
qualifier: located_in
review:
summary: Same as the other extracellular-region assignment, from a Reactome
ficolin-rich granule exocytosis module. Not a functional location for this
cytosolic enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: Bystander secretome/degranulation catalog assignment; PYGL acts in the
cytosol.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0034774
label: secretory granule lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6798748
qualifier: located_in
review:
summary: From a Reactome secretory-granule exocytosis module. PYGL is cytosolic;
granule-lumen localization is a bystander proteomic/degranulation catalog
assignment, not a functional site.
action: MARK_AS_OVER_ANNOTATED
reason: Not a functional location for this cytosolic glycogenolytic enzyme.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:1904813
label: ficolin-1-rich granule lumen
evidence_type: TAS
original_reference_id: Reactome:R-HSA-6800434
qualifier: located_in
review:
summary: From a Reactome ficolin-rich granule exocytosis module. As with the
other granule/extracellular assignments, this is a bystander catalog location,
not the functional site of the cytosolic enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: Not a functional location for this cytosolic glycogenolytic enzyme.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:23533145
qualifier: located_in
review:
summary: PYGL was detected among ~900 proteins in a shotgun proteomic survey of
exosomes from prostatic secretions in urine. This is a high-throughput
proteome-cataloguing localization, not evidence of a functional exosomal role
for this cytosolic enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: Detection in an exosome proteome catalog does not indicate a functional
site; PYGL acts in the cytosol.
supported_by:
- reference_id: PMID:23533145
supporting_text: In pooled EPS-urine exosome samples, ~900 proteins were
detected.
- term:
id: GO:0008184
label: glycogen phosphorylase activity
evidence_type: IDA
original_reference_id: PMID:22225877
qualifier: enables
review:
summary: Zhang et al. directly measured the glycogen phosphorylase catalytic
activity of purified human GP (and its regulation by acetylation/PP1),
providing direct experimental evidence for this core molecular function.
action: ACCEPT
reason: Direct experimental demonstration of the core catalytic activity of PYGL.
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
body glucose is scarce.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-453339
qualifier: located_in
review:
summary: Reactome cytosol assignment for the glycogenolysis reaction (glycogen +
phosphate to glucose-1-phosphate). This is the correct functional location for
PYGL.
action: ACCEPT
reason: Cytosol is the correct site of the glycogenolytic reaction catalyzed by
PYGL; concordant with IBA and UniProt.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71588
qualifier: located_in
review:
summary: Reactome cytosol assignment for the phosphorylase b to a interconversion
reaction. Correct functional location.
action: ACCEPT
reason: Cytosol is the correct site of action; concordant with IBA and UniProt.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71590
qualifier: located_in
review:
summary: Reactome cytosol assignment for glycogen limit-dextrin formation with
release of glucose-1-phosphate. Correct functional location.
action: ACCEPT
reason: Cytosol is the correct site of the glycogenolytic reaction; concordant
with IBA and UniProt.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- term:
id: GO:0002060
label: purine nucleobase binding
evidence_type: IDA
original_reference_id: PMID:12204691
qualifier: enables
review:
summary: Derived from a crystallographic/SPR structure-activity screen of ligands
at the purine allosteric inhibitor site of human liver GP, a drug-discovery
target site. This binding is real structurally but peripheral to the enzyme's
biological function.
action: MARK_AS_OVER_ANNOTATED
reason: Purine-nucleobase binding reflects a pharmacological/inhibitor-screen site
rather than a core physiological binding function; retained but flagged as
over-annotation. Not removed, as it is an experimental IDA.
supported_by:
- reference_id: PMID:12204691
supporting_text: compounds that bind to the purine allosteric inhibitor site.
- term:
id: GO:0005524
label: ATP binding
evidence_type: IDA
original_reference_id: PMID:10949035
qualifier: enables
review:
summary: ATP is a physiological allosteric inhibitor of glycogen phosphorylase,
binding at the nucleotide (AMP) allosteric site; UniProt records inhibition by
ATP among the allosteric controls. The cited crystallographic study of the
active/inactive human liver GP is abstract-only in the cache.
action: ACCEPT
reason: ATP binding at the allosteric nucleotide site is a genuine regulatory
binding function of the enzyme (ATP inhibits GP); experimental IDA, deferring to
the full text read by the curator.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: being activated by AMP and inhibited by ATP,
- term:
id: GO:0005977
label: glycogen metabolic process
evidence_type: IMP
original_reference_id: PMID:10980448
qualifier: involved_in
review:
summary: Involvement in glycogen metabolism supported by structural/functional
study of the human liver enzyme. This is a correct but general parent of the
specific glycogen catabolic process, which better captures PYGL's role.
action: KEEP_AS_NON_CORE
reason: Correct but general; glycogen catabolic process is the precise core BP.
Retained as non-core.
supported_by:
- reference_id: PMID:10980448
supporting_text: Glycogen phosphorylases catalyze the breakdown of glycogen to
glucose-1-phosphate for glycolysis.
- term:
id: GO:0005977
label: glycogen metabolic process
evidence_type: IMP
original_reference_id: PMID:17705025
qualifier: involved_in
review:
summary: GSD6 patients with PYGL mutations show impaired mobilization of glucose
from glycogen, implicating PYGL in glycogen metabolism. Correct but a general
parent of the specific glycogen catabolic process.
action: KEEP_AS_NON_CORE
reason: Correct but general; glycogen catabolic process is the precise core BP.
Retained as non-core.
supported_by:
- reference_id: PMID:17705025
supporting_text: reduced ability to mobilize glucose from glycogen
- term:
id: GO:0008184
label: glycogen phosphorylase activity
evidence_type: IMP
original_reference_id: PMID:10980448
qualifier: enables
review:
summary: Study of the human liver enzyme (active and inactive forms) supports its
glycogen phosphorylase catalytic activity. Redundant with the IDA/EXP/IBA
annotations to the same core function.
action: ACCEPT
reason: Correctly captures the core catalytic activity of PYGL.
supported_by:
- reference_id: PMID:10980448
supporting_text: Glycogen phosphorylases catalyze the breakdown of glycogen to
glucose-1-phosphate for glycolysis.
- term:
id: GO:0008184
label: glycogen phosphorylase activity
evidence_type: IMP
original_reference_id: PMID:17705025
qualifier: enables
review:
summary: GSD6-causing missense mutations in PYGL impair enzyme activity,
supporting that PYGL enables glycogen phosphorylase activity. Concordant with the
core catalytic function.
action: ACCEPT
reason: Disease mutations that reduce enzyme activity support this core molecular
function.
supported_by:
- reference_id: PMID:17705025
supporting_text: reduced ability to mobilize glucose from glycogen
- term:
id: GO:0008184
label: glycogen phosphorylase activity
evidence_type: IMP
original_reference_id: PMID:9529348
qualifier: enables
review:
summary: First identification of PYGL mutations in Hers disease patients,
demonstrating that PYGL encodes the liver glycogen phosphorylase whose deficiency
abolishes activity. Supports this core molecular function.
action: ACCEPT
reason: Disease-causing loss-of-function mutations in PYGL support that it enables
glycogen phosphorylase activity.
supported_by:
- reference_id: PMID:9529348
supporting_text: Deficiency of glycogen phosphorylase in the liver gives rise to
glycogen-storage disease type VI (Hers disease; MIM 232700).
- term:
id: GO:0016208
label: AMP binding
evidence_type: IDA
original_reference_id: PMID:10949035
qualifier: enables
review:
summary: AMP is the classical physiological allosteric activator of glycogen
phosphorylase; the crystal structure of human liver GP in complex with AMP was
solved (UniProt records AMP-binding residues 43-45, 76, 310), and UniProt notes
activation by AMP. A genuine, physiologically important ligand-binding function.
action: ACCEPT
reason: AMP binding at the allosteric activator site is a core regulatory binding
function of the enzyme; supported by structure and by curated binding-site
annotation.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: being activated by AMP and inhibited by ATP,
- term:
id: GO:0016208
label: AMP binding
evidence_type: IDA
original_reference_id: PMID:10980448
qualifier: enables
review:
summary: Structural study of human liver GP; AMP is the physiological allosteric
activator that binds the nucleotide effector site. Duplicate of the other AMP
binding IDA; a core regulatory binding function.
action: ACCEPT
reason: AMP binding at the allosteric activator site is a genuine, physiologically
important binding function of the enzyme.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: being activated by AMP and inhibited by ATP,
- term:
id: GO:0019842
label: vitamin binding
evidence_type: IDA
original_reference_id: PMID:12204691
qualifier: enables
review:
summary: Vitamin binding here refers to the bound pyridoxal 5'-phosphate cofactor
(a vitamin B6 derivative) seen in the crystal structures. This is a very general
term that is captured more precisely by the pyridoxal phosphate binding
annotation.
action: MARK_AS_OVER_ANNOTATED
reason: Overly general term; the specific and informative pyridoxal phosphate
binding term already annotated supersedes it. Retained but flagged.
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
- term:
id: GO:0032052
label: bile acid binding
evidence_type: IDA
original_reference_id: PMID:12204691
qualifier: enables
review:
summary: Derived from the same crystallographic/SPR ligand screen of the purine
allosteric inhibitor site. Bile-acid binding at a drug-target allosteric pocket
is a pharmacological observation, not a physiological function of the enzyme.
action: MARK_AS_OVER_ANNOTATED
reason: Reflects binding of screened ligands at a drug-discovery allosteric site
rather than a biological function; retained but flagged as over-annotation. Not
removed, as it is an experimental IDA.
supported_by:
- reference_id: PMID:12204691
supporting_text: compounds that bind to the purine allosteric inhibitor site.
- term:
id: GO:0042593
label: glucose homeostasis
evidence_type: IMP
original_reference_id: PMID:17705025
qualifier: involved_in
review:
summary: GSD6 caused by PYGL deficiency presents with fasting hypoglycemia,
demonstrating that PYGL contributes to organismal glucose homeostasis by
mobilizing glucose from hepatic glycogen. This is a physiological, systemic role
downstream of the core enzymatic function.
action: KEEP_AS_NON_CORE
reason: Genuine organismal/physiological role, but downstream of and secondary to
the core glycogen catabolic/enzymatic function; retained as non-core.
supported_by:
- reference_id: PMID:17705025
supporting_text: reduced ability to mobilize glucose from glycogen
core_functions:
- description: Pyridoxal-5'-phosphate-dependent glycogen phosphorylase that catalyzes
the rate-limiting step of glycogenolysis, phosphorolytically cleaving alpha-1,4
glycosidic bonds at the non-reducing ends of glycogen to release glucose-1-phosphate,
acting as an active homodimer in the cytosol and allosterically activated by AMP.
molecular_function:
id: GO:0008184
label: glycogen phosphorylase activity
directly_involved_in:
- id: GO:0005980
label: glycogen catabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: PMID:22225877
supporting_text: Glycogen phosphorylase (GP) catalyzes phosphorolytic cleavage
of glycogen to produce glucose-1-phosphate for glucose-dependent tissues when
body glucose is scarce.
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cytoplasm, cytosol"
- description: Binds pyridoxal 5'-phosphate as an essential covalent cofactor (via a
Schiff base to Lys681), which is required for the phosphorolytic catalytic
mechanism of glycogen phosphorylase.
molecular_function:
id: GO:0030170
label: pyridoxal phosphate binding
directly_involved_in:
- id: GO:0005980
label: glycogen catabolic process
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/PYGL/PYGL-uniprot.txt
supporting_text: Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:10949035
title: Activation of human liver glycogen phosphorylase by alteration of the secondary
structure and packing of the catalytic core.
findings: []
- id: PMID:10980448
title: Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.
findings: []
- id: PMID:12204691
title: Structure-activity analysis of the purine binding site of human liver glycogen
phosphorylase.
findings: []
- id: PMID:17705025
title: High frequency of missense mutations in glycogen storage disease type VI.
findings: []
- id: PMID:22225877
title: Acetylation negatively regulates glycogen phosphorylase by recruiting protein
phosphatase 1.
findings: []
- id: PMID:23533145
title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
secretions in urine.
findings: []
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
- id: PMID:25910212
title: Widespread macromolecular interaction perturbations in human genetic disorders.
findings: []
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
- id: PMID:9529348
title: Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis
type VI.
findings: []
- id: Reactome:R-HSA-453339
title: poly((1,4)-alpha-glucosyl) glycogenin-2 + n orthophosphate => glycogenin-2
+ n D-glucose 1-phosphate [PYGL]
findings: []
- id: Reactome:R-HSA-6798748
title: Exocytosis of secretory granule lumen proteins
findings: []
- id: Reactome:R-HSA-6800434
title: Exocytosis of ficolin-rich granule lumen proteins
findings: []
- id: Reactome:R-HSA-71588
title: glycogen phosphorylase (PYGL) dimer b + 2 ATP => glycogen phosphorylase (PYGL)
dimer a + 2 ADP
findings: []
- id: Reactome:R-HSA-71590
title: glycogen-glycogenin-2 + n orthophosphate => limit dextrin-glycogenin-2 +
n D-glucose 1-phosphate [PYGL]
findings: []